P-606 Prognostic factor analysis of locally advanced non-small celllung cancer with surgical resection: Poor disease-free survival in patients with low ...
P-606 Prognostic factor analysis of locally advanced non-small celllung cancer with surgical resection: Poor disease-free survival in patients with low ...
Fourteen patients with previously treated, locally advanced/metastatic transitional cell carcinoma (TCC) of the bladder or ureter received paclitaxel at a ...
Neoadjuvant therapy for rectal carcinoma modifies morphology and natural history of the tumor. Colloid response defined by predominant colloid changes with...
PURPOSE: The aim of this study was to determine the effect of surgeon specialty on disease-free survival and local control in patients with adenocarcinoma ...
BACKGROUND:Radiotherapy may improve the outcome of patients with pancreatic cancer but at an increased cost. In this study, the authors evaluated the cost-...
Background: Although patients with differentiated thyroid cancer (DTC) of follicular cell origin usually have an excellent prognosis, some patients die fro...
Introduction In patients with a primary melanoma 鈮 1.0mm in Breslow thickness, the rate of metastasis to regional lymph nodes, as determined by sentinel n...
6114Introduction: Symptomatic patients (pts) with performance status (KPS) 70-80 with locally advanced or metastatic breast cancer (MBC) have worse prognosis than pts with good performance status and are often excluded from clinical tria...
